Description
Indicated either alone or in combination with systemic therapy, in the
treatment of primary and secondary skin infections caused by sensitive strains
of Staphylococcus aureus, streptococcus spp and Corynebacterium
minutissimum.
Primary skin infections that may be expected to respond to treatment with
fusidic acid applied topically include: impetigo contagiosa, superficial
folliculitis, sycosis barbae, paronychia and erythrasma; also such secondary
skin infections as infected eczematoid dermatitis, infected contact dermatitis
and infected cuts /abrasions.
Signup to K2
Register today for a Kays Medical trade account and begin using K2 to place orders securely and conveniently for immediate delivery.
Click here to signup or if already registered click here to login.